Table 1.
Stratification of sample and comparison to remaining facilities
| Cell description | Non-participating N = 3366 (%) | Survey sample N = 405 (%) |
|---|---|---|
| 1. NRT*, For-Profit, Methadone |
12 (0.4) |
3 (0.7) |
| 2. NRT, Not For-Profit, Methadone |
44 (1.3) |
12 (3.0) |
| 3. NRT, Not For-Profit, No Methadone |
123 (3.7) |
31 (7.77) |
| 4. NRT, For-Profit, No Methadone |
35 (1.0) |
12 (3.0) |
| 5. No NRT, For-Profit, Methadone |
399 (11.9) |
45 (11.1) |
| 6. No NRT, Not For-Profit, Methadone |
231 (6.9) |
27 (6.7) |
| 7. No NRT, Not For-Profit, No Methadone |
1442 (42.8) |
163 (40.2) |
| 8. No NRT, For-Profit, No Methadone | 1080 (32.1) | 112 (27.7) |
*NRT = Nicotine Replacement Therapy.
** Compared to all U.S. facilities, facilities in our sample were more likely to provide nicotine replacement, more likely to be rural, more likely to be certified by a mental health department, and less likely to be certified or licensed by a state substance abuse treatment facility.